Pine Labs listed at a 14% premium on November 14, 2025 (₹252 vs ₹221 issue) but has since slid to ~₹157 — 29% below issue price. Q3 FY26 turned profitable yet the stock kept falling. Full post-listing review explaining what went wrong, the geopolitical impact, audit overhang, analyst targets, and a buy/hold/sell framework.
IPO Articles & Analysis
Insights, how-to guides, and market updates from the ipomarket.in research team.